Literature DB >> 12680280

[Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].

Sylvia Kinzel1, Sven Hein, Thaddeus Stopinski, Johannes Koch, Arno Buecker, Hans-Peter Treusacher, Axel Schmachtenberg, Thomas Jansen, Michael Eble, Wernen Küpper.   

Abstract

This study describes the experience with hypofractionated radiation therapy of squamous cell carcinoma and melanoma in dogs and cats. A total dose of 32-48 Gray (Gy) was delivered once a week in 8 Gy fractions. 34 animals in which a complete surgical excision was impossible were treated. There was no tumor detectable macroscopically in 14 patients at the beginning of radiation therapy. In 20 animals the median volume of the tumor was 9.9 cm3. The median survival times and the local tumor control of squamous cell carcinoma of the oral and nasal cavities and of the body are comparable to results which were reached with a Monday-Wednesday-Friday scheme. For the treatment of Melanoma the hypofractionated radiation therapy is first choice. There are no significant side effects. Late side effects did not occur. 88% of the owners are satisfied with this kind of treatment and would choose it again.

Entities:  

Mesh:

Year:  2003        PMID: 12680280

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  1 in total

Review 1.  Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The "La Cittadina Fondazione" Experience.

Authors:  Mario Dolera; Luca Malfassi; Nancy Carrara; Sara Finesso; Silvia Marcarini; Giovanni Mazza; Simone Pavesi; Massimo Sala; Gaetano Urso
Journal:  Cancers (Basel)       Date:  2018-01-24       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.